A detailed history of Susquehanna International Group, LLP transactions in Armata Pharmaceuticals, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 29,786 shares of ARMP stock, worth $60,763. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,786
Previous 64,012 53.47%
Holding current value
$60,763
Previous $176,000 60.23%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.1 - $3.3 $71,874 - $112,945
-34,226 Reduced 53.47%
29,786 $70,000
Q2 2024

Aug 15, 2024

SELL
$2.4 - $3.9 $57,098 - $92,784
-23,791 Reduced 27.1%
64,012 $176,000
Q1 2024

May 07, 2024

BUY
$2.81 - $4.18 $246,726 - $367,016
87,803 New
87,803 $367,000
Q4 2022

Feb 14, 2023

BUY
$0.94 - $4.16 $9,632 - $42,627
10,247 New
10,247 $12,000
Q1 2022

May 16, 2022

SELL
$3.9 - $6.32 $46,924 - $76,042
-12,032 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$2.96 - $5.86 $35,614 - $70,507
12,032 New
12,032 $66,000
Q1 2020

May 15, 2020

SELL
$2.58 - $4.85 $37,895 - $71,236
-14,688 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$3.16 - $4.54 $46,414 - $66,683
14,688 New
14,688 $48,000

Others Institutions Holding ARMP

About Armata Pharmaceuticals, Inc.


  • Ticker ARMP
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,144,700
  • Market Cap $73.7M
  • Description
  • Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...
More about ARMP
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.